| P2093 | author name string | Osamu Yokosuka | |
| | Hitoshi Maruyama | |
| | Tadashi Sekimoto | |
| P2860 | cites work | Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma | Q27014969 |
| | Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS | Q28278903 |
| | Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US. | Q30439812 |
| | Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases | Q30455788 |
| | Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: a pilot study | Q30460933 |
| | Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CT | Q30462259 |
| | Contrast enhanced ultrasound of hepatocellular carcinoma | Q30478156 |
| | Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm. | Q30479583 |
| | Hepatocellular carcinoma treated with sorafenib: early detection of treatment response and major adverse events by contrast-enhanced US. | Q34321931 |
| | Evaluation of contrast-enhanced ultrasonography using perfluorobutane (Sonazoid(®)) in patients with small hepatocellular carcinoma: comparison with dynamic computed tomography | Q36216549 |
| | WFUMB Safety Symposium on Echo-Contrast Agents: nature and types of ultrasound contrast agents | Q36708009 |
| | Multistep human hepatocarcinogenesis: correlation of imaging with pathology | Q37370018 |
| | Contrast-enhanced ultrasound techniques for guiding and assessing response to locoregional treatments for hepatocellular carcinoma | Q37771184 |
| | Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma | Q37892845 |
| | Diagnostic imaging of hepatocellular carcinoma: recent progress | Q37972809 |
| | Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan: 2014 update | Q38271758 |
| | Recent progress in radiofrequency ablation therapy for hepatocellular carcinoma | Q38271762 |
| | CEUS: An essential component in a multimodality approach to small nodules in patients at high-risk for hepatocellular carcinoma | Q38532594 |
| | Contrast enhanced ultrasound in the evaluation and percutaneous treatment of hepatic and renal tumors | Q38533339 |
| | Diagnosing Borderline Hepatic Nodules in Hepatocarcinogenesis: Imaging Performance. | Q38535294 |
| | Contrast-enhanced intraoperative ultrasonography for vascular imaging of hepatocellular carcinoma: clinical and biological significance | Q39245130 |
| | Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma | Q40117915 |
| | Clinical translation in the treatment of hepatocellular carcinoma following the introduction of contrast-enhanced ultrasonography with Sonazoid | Q42244730 |
| | The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy | Q43108443 |
| | Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent | Q43218424 |
| | Definition of contrast enhancement phases of the liver using a perfluoro-based microbubble agent, perflubutane microbubbles | Q43284659 |
| | Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT. | Q43635610 |
| | Depiction of portal supply in early hepatocellular carcinoma and dysplastic nodule: value of pure arterial ultrasound imaging in hepatocellular carcinoma | Q43729882 |
| | Efficacy of contrast-enhanced ultrasonography in radiofrequency ablation for hepatocellular carcinoma | Q43788027 |
| | New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography | Q45364465 |
| | Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging | Q45806482 |
| | Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial. | Q45960644 |
| | Three-dimensional contrast-enhanced sonography of vascular patterns of focal liver tumors: pilot study of visualization methods | Q46189374 |
| | Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas: the usefulness of sonazoid-enhanced harmonic sonography | Q46192676 |
| | Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions | Q46310316 |
| | Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography. | Q46357723 |
| | Ultrasonography fusion imaging system increases the chance of radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on conventional ultrasonography | Q46444940 |
| | Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI. | Q46593010 |
| | Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography | Q46722558 |
| | Physicochemical characteristics of Sonazoid, a new contrast agent for ultrasound imaging | Q46768075 |
| | Heterogeneous staining in the liver parenchyma after the injection of perflubutane microbubble contrast agent | Q48568313 |
| | Usefulness of intraoperative diagnosis of hepatic tumors located at the liver surface and hepatic segmental visualization using indocyanine green-photodynamic eye imaging | Q50444751 |
| | Visualization of blood drainage area from hypervascular hepatocellular carcinoma on ultrasonographic images during hepatic arteriogram: Comparison with depiction of drainage area on contrast-enhanced ultrasound. | Q50511921 |
| | Combined intraoperative use of contrast-enhanced ultrasonography imaging using a sonazoid and fluorescence navigation system with indocyanine green during anatomical hepatectomy. | Q50512138 |
| | Cost-effectiveness analysis on the surveillance for hepatocellular carcinoma in liver cirrhosis patients using contrast-enhanced ultrasonography. | Q51175477 |
| | Intensity-Based Assessment of Microbubble-Enhanced Ultrasonography: Phase-Related Diagnostic Ability for Cellular Differentiation of Hepatocellular Carcinoma. | Q51719692 |
| | The gross classification of hepatocellular carcinoma: usefulness of contrast-enhanced US. | Q51741309 |
| | Computer-aided diagnosis of focal liver lesions by use of physicians' subjective classification of echogenic patterns in baseline and contrast-enhanced ultrasonography. | Q51849300 |
| | Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chroni | Q53001457 |
| | Utility of contrast-enhanced ultrasound with perflubutane for diagnosing the macroscopic type of small nodular hepatocellular carcinomas. | Q53062216 |
| | Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography. | Q53065620 |
| | Natural history of postvascular-phase iso-enhanced lesions on the sonogram in chronic liver diseases. | Q53088943 |
| | Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma. | Q53090096 |
| | Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma. | Q53183597 |
| | Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with Gd-EOB-DTPA to detect small hepatocellular carcinoma. | Q53184048 |
| | Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma. | Q53248634 |
| | Sonazoid-enhanced ultrasonography for evaluation of the enhancement patterns of focal liver tumors in the late phase by intermittent imaging with a high mechanical index. | Q53362427 |
| | Contrast-enhanced intraoperative ultrasound for hepatocellular carcinoma: high sensitivity of diagnosis and therapeutic impact | Q56773132 |
| | Double-Contrast Ultrasound: A Novel Surveillance Tool for Hepatocellular Carcinoma | Q57763208 |
| | Usefulness of Combination of Imaging Modalities in the Diagnosis of Hepatocellular Carcinoma Using Sonazoid®-Enhanced Ultrasound, Gadolinium Diethylene-Triamine-Pentaacetic Acid-Enhanced Magnetic Resonance Imaging, and Contrast-Enhanced Computed Tom | Q57763286 |
| | Newly Developed Novel Ultrasound Technique, Defect Reperfusion Ultrasound Imaging, Using Sonazoid in the Management of Hepatocellular Carcinoma | Q57763337 |
| | Radiofrequency Ablation for Hepatocellular Carcinoma: Assistant Techniques for Difficult Cases | Q57763382 |
| | Radiofrequency ablation guided by contrast harmonic sonography using perfluorocarbon microbubbles (Sonazoid) for hepatic malignancies: an initial experience | Q57763392 |
| | Usefulness of the Post-Vascular Phase of Contrast-Enhanced Ultrasonography with Sonazoid in the Evaluation of Gross Types of Hepatocellular Carcinoma | Q57763418 |
| | Imaging of Hepatocellular Carcinoma: Qualitative and Quantitative Analysis of Postvascular Phase Contrast-Enhanced Ultrasonography with Sonazoid | Q57763553 |
| | Sonazoid-Enhanced Ultrasonography for Diagnosis of Hepatic Malignancies: Comparison with Contrast-Enhanced CT | Q57763616 |
| | New sonographic techniques for the diagnosis and treatment of hepatocellular carcinoma | Q81314543 |
| | Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma | Q82333264 |
| | Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma | Q83130692 |
| | Usefulness of sonazoid-ultrasonography during hepatectomy in patients with liver tumors: A preliminary study | Q83275653 |
| | Heterogeneity of microbubble accumulation: a novel approach to discriminate between well-differentiated hepatocellular carcinomas and regenerative nodules | Q83286864 |
| | Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images | Q83706741 |
| | Comparison of Kupffer-phase Sonazoid-enhanced sonography and hepatobiliary-phase gadoxetic acid-enhanced magnetic resonance imaging of hepatocellular carcinoma and correlation with histologic grading | Q83732251 |
| | Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma | Q84179014 |
| | Three-dimensional staining of liver segments with an ultrasound contrast agent as an aid to anatomic liver resection | Q84342835 |
| | Contrast-enhanced sonography-guided radiofrequency ablation for the local recurrence of previously treated hepatocellular carcinoma undetected by B-mode sonography | Q84463509 |
| | Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma | Q84589506 |
| | Improved diagnosis of well‐differentiated hepatocellular carcinoma with gadolinium ethoxybenzyl diethylene triamine pentaacetic acid‐enhanced magnetic resonance imaging and Sonazoid contrast‐enhanced ultrasonography | Q85120671 |
| | Pretreatment microbubble-induced enhancement in hepatocellular carcinoma predicts intrahepatic distant recurrence after radiofrequency ablation | Q86196353 |
| | Diagnosis of hepatocellular carcinoma nodules in patients with chronic liver disease using contrast-enhanced sonography: usefulness of the combination of arterial- and kupffer-phase enhancement patterns | Q86830329 |
| | Usefulness of contrast-enhanced ultrasonography using Sonazoid for the assessment of therapeutic response to percutaneous radiofrequency ablation for hepatocellular carcinoma | Q88055813 |
| | Linear enhancement after radio-frequency ablation for hepatocellular carcinoma: is it a sign of recurrence? | Q95423570 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 421-433 | |
| P577 | publication date | 2015-12-22 | |
| P1433 | published in | Journal of Gastroenterology | Q15764399 |
| P1476 | title | Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience | |
| P478 | volume | 51 | |